Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Versus Delayed Hypertonic Saline Inhalation in Treatment-Naïve NTM-LD
NCT07647575Recruiting
- Sponsor
- Taipei Veterans General Hospital
- Start
- Oct 2025
- Primary completion
- Apr 2028
- Countries
- 1
01
Overview
Randomised trial of hypertonic saline in nontuberculous mycobacterial lung disease and bronchiectasis (2 arms), sponsored by Taipei Veterans General Hospital. Primary endpoint: Total Respiratory Severity Score at 6 months. Started Oct 2025; status: recruiting.
02
Drugs
hypertonic saline
03
Conditions
nontuberculous mycobacterial lung diseasebronchiectasis
Beyond the preview
Go deeper on NCT07647575.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07647575.